These factors included elevated levels of body mass index, PD-L1 tumor proportion score (TPS), and albumin, as well as decreased levels of serum cytokeratin 19 fragment antigen 211, neuron-specific enolase, squamous cell carcinoma antigen, platelets, and C-reactive protein (all p < 0.05). Here, ENO2 is linked to neoplasm.